Two new drugs added to WHO list of COVID-19 therapies

A World Health Organization (WHO) panel has given the green light to two new drugs to treat COVID-19.

US-based Eli Lilly’s baricitinib (Olumiant), a Janus kinase inhibitor, and GlaxoSmithKline and Vir Biotechnology’s sotrovimab, a monoclonal antibody, were recommended in new WHO guidelines, published in the British Medical Journal.